EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, KZIA: Kazia Therapeutics Ltd ADR

21 Oct 25 15:42
LAST:

7.030

CHANGE:
 0.36		OPEN:
7.500		HIGH:
7.500		ASK:
0.000		VOLUME:
24.5K
CHG(%):
4.87		PREV:
7.390		LOW:
6.890		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
21 Oct 257.3507.3906.8907.03026.4K
20 Oct 257.0907.3906.9507.39026.6K
17 Oct 257.0407.0606.7907.00028.2K
16 Oct 257.1807.2906.9506.99037.7K
15 Oct 257.0107.2206.9267.22029.2K
14 Oct 256.9707.0806.8206.98015.6K
13 Oct 257.0907.0906.7896.81012.0K
10 Oct 257.2107.3006.9206.98043.5K
09 Oct 257.0207.4486.9707.18052.1K
08 Oct 257.2107.3206.7357.16055.7K

COMPANY PROFILE

Name:Kazia Therapeutics Ltd ADR
About:Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in South Korea. Its lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase 3 clinical trial, for the treatment of glioblastoma, isocitrate dehydrogenase-mutant glioma, diffuse intrinsic pontine glioma, atypical teratoid/rhabdoid tumor, brain metastases, primary central nervous system (CNS) lymphoma, triple negative breast cancer, and ovarian cancer. The company also develops EVT801, a small-molecule selective inhibitor of vascular endothelial growth factor receptor 3, which is in Phase 1 clinical trial, to treat advanced solid tumors. It has collaborations with the Australian and New Zealand Children's Haematology/Oncology Group, OIMR Berghofer Medical Research Institute, Genentech Inc., Global Coalition for Adaptive Research, Vivesto AB, Simcere Pharmaceutical Group Ltd, Evotec SE, and Sovargen Co., Ltd. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:Three International Towers, Sydney, NSW, Australia, 2000
Website:https://www.kaziatherapeutics.com
CUSIP:67010F103
CIK:0001055886
ISIN:US48669G1058
FIGI:BBG000KC7878

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:7.131.4%
MA10:7.070.6%
MA20:7.080.7%
MA50:7.557.4%
MA100:7.8411.5%
MA200:4.8445.3%
STO9:34.50
STO14:42.60
RSI14:52.83
WPR14:-33.33
MTM14:0.72
ROC14:0.11 
ATR:0.48 
Week High:7.395.1%
Week Low:6.793.5%
Month High:8.0013.8%
Month Low:6.2045.3%
Year High:12.8682.9%
Year Low:0.511,278.3%
Volatility:25.18 

RECENT SPLITS

Date Ratio
17 Apr 20251-5
28 Oct 20241-10
14 Jul 20171-4
28 Jan 20133038-1000
03 Jan 20121-5

RECENT DIVIDENDS

Date Amount
28 Jan 2013$4.09